MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients

Cheppail Ramachandran, Antonieta Sauerteig, Kasi S. Sridhar, Richard J Thurer, Awtar Krishan

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Lung-tumor cells from pleural effusion of four refractory patients and in cell lines established from them were analyzed for anthracycline retention, cytotoxicity, and MDR-1 gene and P-glycoprotein expression. Murine leukemic P388 and doxorubicin-resistant P388/R84 lines were used as controls. The 50% growth-inhibitory concentration (IC50) for doxorubicin among lung-tumor lines varied from 0.16 to 0.31 μM in soft agar. Heterogeneity in doxorubicin or daunorubicin retention and response to the efflux-blocking action of 25 μm prochlorperazine was noted in pleural effusion of FCCL-1,-4, and-8. Among the cell lines established, an efflux-blocking effect in a subpopulation was noticed only in FCCL-1 and-4. Although the MDR-1 gene was present in all cell lines, including P388, its expression was pronounced only in P388/R84 and FCCL-1. In situ hybridization of antisense RNA probe to tumor cells showed high heterogeneity for MDR-1 message in the human lung-tumor cells as compared with the murine cells. Northern and slot blot hybridization confirmed in situ hybridization in lines with high levels of MDR-1 expression. The synthesis of MDR-1 mRNA and P-glycoprotein in tumor lines was correlated. The results suggest that because of extensive tumor-cell heterogeneity in human tumors, monitoring of MDR expression by in situ hybridization, quantitation of P0glycoprotein content by laser flow cytometry (and/or immunohistochemical methods), and drug efflux (by laser flow cytometry) may be the best ways to monitor multidrug resistance in human tumors.

Original languageEnglish
Pages (from-to)431-441
Number of pages11
JournalCancer Chemotherapy and Pharmacology
Volume31
Issue number6
DOIs
StatePublished - Nov 1 1993

Fingerprint

MDR Genes
Anthracyclines
Cytotoxicity
Gene expression
Refractory materials
Tumors
Cells
Gene Expression
Lung
In Situ Hybridization
Neoplasms
Doxorubicin
Flow cytometry
P-Glycoprotein
Pleural Effusion
Cell Line
Inhibitory Concentration 50
Flow Cytometry
Lasers
Genes

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Cite this

MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients. / Ramachandran, Cheppail; Sauerteig, Antonieta; Sridhar, Kasi S.; Thurer, Richard J; Krishan, Awtar.

In: Cancer Chemotherapy and Pharmacology, Vol. 31, No. 6, 01.11.1993, p. 431-441.

Research output: Contribution to journalArticle

Ramachandran, Cheppail ; Sauerteig, Antonieta ; Sridhar, Kasi S. ; Thurer, Richard J ; Krishan, Awtar. / MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients. In: Cancer Chemotherapy and Pharmacology. 1993 ; Vol. 31, No. 6. pp. 431-441.
@article{3f3158f72f32431d9fea5e6c4e66c221,
title = "MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients",
abstract = "Lung-tumor cells from pleural effusion of four refractory patients and in cell lines established from them were analyzed for anthracycline retention, cytotoxicity, and MDR-1 gene and P-glycoprotein expression. Murine leukemic P388 and doxorubicin-resistant P388/R84 lines were used as controls. The 50{\%} growth-inhibitory concentration (IC50) for doxorubicin among lung-tumor lines varied from 0.16 to 0.31 μM in soft agar. Heterogeneity in doxorubicin or daunorubicin retention and response to the efflux-blocking action of 25 μm prochlorperazine was noted in pleural effusion of FCCL-1,-4, and-8. Among the cell lines established, an efflux-blocking effect in a subpopulation was noticed only in FCCL-1 and-4. Although the MDR-1 gene was present in all cell lines, including P388, its expression was pronounced only in P388/R84 and FCCL-1. In situ hybridization of antisense RNA probe to tumor cells showed high heterogeneity for MDR-1 message in the human lung-tumor cells as compared with the murine cells. Northern and slot blot hybridization confirmed in situ hybridization in lines with high levels of MDR-1 expression. The synthesis of MDR-1 mRNA and P-glycoprotein in tumor lines was correlated. The results suggest that because of extensive tumor-cell heterogeneity in human tumors, monitoring of MDR expression by in situ hybridization, quantitation of P0glycoprotein content by laser flow cytometry (and/or immunohistochemical methods), and drug efflux (by laser flow cytometry) may be the best ways to monitor multidrug resistance in human tumors.",
author = "Cheppail Ramachandran and Antonieta Sauerteig and Sridhar, {Kasi S.} and Thurer, {Richard J} and Awtar Krishan",
year = "1993",
month = "11",
day = "1",
doi = "10.1007/BF00685031",
language = "English",
volume = "31",
pages = "431--441",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients

AU - Ramachandran, Cheppail

AU - Sauerteig, Antonieta

AU - Sridhar, Kasi S.

AU - Thurer, Richard J

AU - Krishan, Awtar

PY - 1993/11/1

Y1 - 1993/11/1

N2 - Lung-tumor cells from pleural effusion of four refractory patients and in cell lines established from them were analyzed for anthracycline retention, cytotoxicity, and MDR-1 gene and P-glycoprotein expression. Murine leukemic P388 and doxorubicin-resistant P388/R84 lines were used as controls. The 50% growth-inhibitory concentration (IC50) for doxorubicin among lung-tumor lines varied from 0.16 to 0.31 μM in soft agar. Heterogeneity in doxorubicin or daunorubicin retention and response to the efflux-blocking action of 25 μm prochlorperazine was noted in pleural effusion of FCCL-1,-4, and-8. Among the cell lines established, an efflux-blocking effect in a subpopulation was noticed only in FCCL-1 and-4. Although the MDR-1 gene was present in all cell lines, including P388, its expression was pronounced only in P388/R84 and FCCL-1. In situ hybridization of antisense RNA probe to tumor cells showed high heterogeneity for MDR-1 message in the human lung-tumor cells as compared with the murine cells. Northern and slot blot hybridization confirmed in situ hybridization in lines with high levels of MDR-1 expression. The synthesis of MDR-1 mRNA and P-glycoprotein in tumor lines was correlated. The results suggest that because of extensive tumor-cell heterogeneity in human tumors, monitoring of MDR expression by in situ hybridization, quantitation of P0glycoprotein content by laser flow cytometry (and/or immunohistochemical methods), and drug efflux (by laser flow cytometry) may be the best ways to monitor multidrug resistance in human tumors.

AB - Lung-tumor cells from pleural effusion of four refractory patients and in cell lines established from them were analyzed for anthracycline retention, cytotoxicity, and MDR-1 gene and P-glycoprotein expression. Murine leukemic P388 and doxorubicin-resistant P388/R84 lines were used as controls. The 50% growth-inhibitory concentration (IC50) for doxorubicin among lung-tumor lines varied from 0.16 to 0.31 μM in soft agar. Heterogeneity in doxorubicin or daunorubicin retention and response to the efflux-blocking action of 25 μm prochlorperazine was noted in pleural effusion of FCCL-1,-4, and-8. Among the cell lines established, an efflux-blocking effect in a subpopulation was noticed only in FCCL-1 and-4. Although the MDR-1 gene was present in all cell lines, including P388, its expression was pronounced only in P388/R84 and FCCL-1. In situ hybridization of antisense RNA probe to tumor cells showed high heterogeneity for MDR-1 message in the human lung-tumor cells as compared with the murine cells. Northern and slot blot hybridization confirmed in situ hybridization in lines with high levels of MDR-1 expression. The synthesis of MDR-1 mRNA and P-glycoprotein in tumor lines was correlated. The results suggest that because of extensive tumor-cell heterogeneity in human tumors, monitoring of MDR expression by in situ hybridization, quantitation of P0glycoprotein content by laser flow cytometry (and/or immunohistochemical methods), and drug efflux (by laser flow cytometry) may be the best ways to monitor multidrug resistance in human tumors.

UR - http://www.scopus.com/inward/record.url?scp=0027459423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027459423&partnerID=8YFLogxK

U2 - 10.1007/BF00685031

DO - 10.1007/BF00685031

M3 - Article

C2 - 8095859

AN - SCOPUS:0027459423

VL - 31

SP - 431

EP - 441

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 6

ER -